Senti Biosciences Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
SNTI Nasdaq 8731

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Senti Biosciences Inc

Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights - Mar 21st, 2024 8:05 pm
Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program - Jan 5th, 2024 9:05 pm
Senti Bio (SNTI) Rises as FDA Clears IND for Cancer Candidate - Dec 26th, 2023 4:32 pm
Why Is Blood Cancer Focused Senti Biosciences Stock Trading Higher Today? - Dec 22nd, 2023 5:12 pm
Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia - Dec 22nd, 2023 11:30 am
Senti Bio Announces Third Quarter 2023 Results and Pipeline Updates - Nov 13th, 2023 9:15 pm
Senti Bio Announces New Strategic Collaboration with Celest Therapeutics for Clinical Development of SENTI-301A in China - Nov 6th, 2023 9:05 pm
Senti Bio Announces Multiple Data Presentations at the Society for Immunotherapy of Cancer Annual Meeting - Oct 31st, 2023 1:06 pm
Senti Bio Announces Multiple Data Presentations at the Society for Immunotherapy of Cancer 2023 Meeting - Sep 27th, 2023 1:05 pm
Senti Bio to Participate in Upcoming Conferences - Sep 26th, 2023 8:05 pm
Senti Bio to Participate in Upcoming Investor Conferences - Sep 5th, 2023 12:30 pm
Senti Biosciences, Inc. (SNTI) Reports Q2 Loss, Misses Revenue Estimates - Aug 11th, 2023 1:50 pm
Senti Bio Announces Second Quarter 2023 Results and Pipeline Updates - Aug 11th, 2023 12:35 pm
Senti Bio Announces Closing of Transaction Leveraging its CMC Capabilities into a Cell and Gene Therapy Manufacturing Innovation Business Backed by Celadon Partners - Aug 10th, 2023 12:35 pm
Here's Why Senti Biosciences (NASDAQ:SNTI) Must Use Its Cash Wisely - Jun 5th, 2023 12:04 pm
Senti Bio Highlights Initial Gene Circuit Data From Collaborations at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - May 20th, 2023 12:05 pm
Senti Bio Announces First Quarter 2023 Results and Pipeline Updates - May 9th, 2023 8:05 pm
Senti Bio Announces Multiple Data Presentations at the American Society of Gene and Cell Therapy 2023 Annual Meeting - May 2nd, 2023 8:45 pm